Pharma Journalist -

Rafael Pharmaceuticals announced that it has entered into an out-licensing agreement with Ono Pharmaceutical Co., Ltd. (“Ono”), a pharmaceutical company committed to creating innovative…
Read More...

AbbVie Inc. and Allergan plc announced that the companies have entered into a definitive transaction agreement under which AbbVie will acquire Allergan in a cash and stock transaction…
Read More...

The European Investment Bank (EIB) has taken a further step forward in fostering innovation in the Spanish and European pharmaceutical sector. By granting a €120 MM loan to Almirall…
Read More...

SMi Reports: New brochure released for the 2019 Pharmaceutical Cleanroom Technology Europe conference taking place in London on 9th and 10th October Since the release of the agenda for…
Read More...

Clinigen Group plc announces that its Commercial Medicines business has signed an exclusive agreement with Accord Healthcare (‘Accord’) to supply and distribute Clinigen’s speciality…
Read More...

Prestige BioPharma (herein, Prestige) announced positive top-line results from a Phase III global clinical trial (Troika) evaluating the efficacy, safety, and pharmacokinetics (PK) of…
Read More...

Gilead Sciences, Inc. and Carna Biosciences Inc. announced that the companies have entered into a research and development collaboration to develop and commercialize small molecule…
Read More...

GENFIT, a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver-related diseases,…
Read More...

SMi reports: Taro Pharmaceuticals, Purdue Pharma and Sakari Consultants to present at HPAPI USA taking place on October 21st – 22nd in Boston With a massive growth within the HPAPI…
Read More...

Arrowhead Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to ARO-APOC3 for the treatment of familial chylomicronemia…
Read More...